Medical Communications, AI Health Tech · near ·
AI 'Content OS' Providers Becoming Key M&A Targets in Health and Pharma Communications by Late 2026
The pharmaceutical commercialisation model is undergoing a fundamental shift due to the widespread deployment of 'regulation-native' Generative AI for content production. This is driving M&A activity towards companies offering modular content platforms and 'content OS' vendors that can integrate data, content generation, and omnichannel delivery, moving away from point solutions and single AI tools.
Part of the Healthcare & Life Sciences Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.